TR200001876T2 - HIV proteaz inhibitörünün bisülfat tuzu. - Google Patents

HIV proteaz inhibitörünün bisülfat tuzu.

Info

Publication number: TR200001876T2
Authority: TR; Turkey
Prior art keywords: protease inhibitor; hiv protease; bisulfate salt; salt; following formula
Prior art date: 1998-01-20

Application number

TR2000/01876T

Other languages

English (en)

Turkish (tr)

Inventor

Singh Janak

Pudipeddi Madhusudhan

D. Lindrud Mark

Original Assignee

Bristol-Myers Squibb Company

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-20

Filing date

1998-12-22

Publication date

2000-11-21

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22104737&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200001876(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-12-22 Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company

2000-11-21 Publication of TR200001876T2 publication Critical patent/TR200001876T2/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pyridine Compounds (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

TR2000/01876T 1998-01-20 1998-12-22 HIV proteaz inhibitörünün bisülfat tuzu. TR200001876T2 (tr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US7196898P	1998-01-20	1998-01-20

Publications (1)

Publication Number	Publication Date
TR200001876T2 true TR200001876T2 (tr)	2000-11-21

Family

ID=22104737

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TR2000/01876T TR200001876T2 (tr)	1998-01-20	1998-12-22	HIV proteaz inhibitörünün bisülfat tuzu.

Country Status (38)

Country	Link
US (1)	US6087383A (et)
EP (1)	EP1056722B1 (et)
JP (2)	JP4860037B2 (et)
KR (1)	KR100559283B1 (et)
CN (1)	CN1116282C (et)
AR (1)	AR014417A1 (et)
AT (1)	ATE219057T1 (et)
AU (1)	AU735875B2 (et)
BG (1)	BG64774B1 (et)
BR (1)	BR9814736A (et)
CA (1)	CA2317736C (et)
CO (1)	CO4970820A1 (et)
CZ (1)	CZ293507B6 (et)
DE (1)	DE69806067T2 (et)
DK (1)	DK1056722T3 (et)
EE (1)	EE04434B1 (et)
EG (1)	EG23936A (et)
ES (1)	ES2178300T3 (et)
GE (1)	GEP20033026B (et)
HU (1)	HU227196B1 (et)
IL (2)	IL137384A0 (et)
LT (1)	LT4780B (et)
LV (1)	LV12522B (et)
MY (1)	MY114838A (et)
NO (1)	NO315605B1 (et)
NZ (1)	NZ504417A (et)
PE (1)	PE20000185A1 (et)
PL (1)	PL190744B1 (et)
PT (1)	PT1056722E (et)
RO (1)	RO118869B1 (et)
RU (1)	RU2186070C2 (et)
SK (1)	SK283975B6 (et)
TR (1)	TR200001876T2 (et)
TW (1)	TW531531B (et)
UA (1)	UA59432C2 (et)
UY (1)	UY25345A1 (et)
WO (1)	WO1999036404A1 (et)
ZA (1)	ZA9956B (et)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE314343T1 (de)	2000-06-30	2006-01-15	Elan Pharm Inc	Verbindungen zur behandlung der alzheimerischen krankheit
EP1392645A2 (en) *	2001-05-22	2004-03-03	Elan Pharmaceuticals, Inc.	Aza hydroxylated ethyl amine compounds
US7193065B2 (en) *	2001-07-13	2007-03-20	Roche Diagnostics Operations, Inc.	Protease inhibitor conjugates and antibodies useful in immunoassay
US7157561B2 (en) *	2001-07-13	2007-01-02	Roche Diagnostics Operations, Inc.	Methods of inhibiting transmission of a costimulatory signal of lymphocytes
AU2004206821C1 (en) *	2003-01-14	2009-10-01	Gilead Sciences, Inc.	Compositions and methods for combination antiviral therapy
TW200534879A (en) *	2004-03-25	2005-11-01	Bristol Myers Squibb Co	Coated tablet formulation and method
CN101565398B (zh) *	2004-05-04	2011-12-14	布里斯托尔-迈尔斯斯奎布公司	制备阿扎那韦硫酸氢盐的方法和新的形式
US20050256314A1 (en) *	2004-05-04	2005-11-17	Soojin Kim	Process employing controlled crystallization in forming crystals of a pharmaceutical
US7829720B2 (en)	2004-05-04	2010-11-09	Bristol-Myers Squibb Company	Process for preparing atazanavir bisulfate and novel forms
US20050288343A1 (en) *	2004-05-19	2005-12-29	Andrew Rusowicz	Process of preparing substituted carbamates and intermediates thereof
TWI415635B (zh) *	2004-05-28	2013-11-21	必治妥施貴寶公司	加衣錠片調製物及製備彼之方法
CA2588466A1 (en) *	2004-12-03	2006-06-08	Merck & Co., Inc.	Use of atazanavir for improving the pharmacokinetics of drugs metabolized by ugt1a1
US7642049B2 (en) *	2006-06-30	2010-01-05	Bristol-Myers Squibb Company	Method for identifying HIV-1 protease inhibitors with reduced metabolic affects through detection of human resistin polymorphisms
JP5599611B2 (ja) *	2006-07-21	2014-10-01	ギリアードサイエンシーズ，インコーポレイテッド	抗ウイルスプロテアーゼインヒビター
BG66056B1 (bg) *	2006-10-05	2010-12-30	Красимир ДЕЧЕВ	Метод и инсталация за производство на трисезонна добавка към дизелово гориво
JP2010529196A (ja)	2007-06-12	2010-08-26	コンサートファーマシューティカルズインコーポレイテッド	アザペプチド誘導体
MX2009013461A (es) *	2007-06-22	2010-01-15	Bristol Myers Squibb Co	Composiciones comprimidas que contienen atazanavir.
DK2170292T3 (da) *	2007-06-22	2014-04-07	Bristol Myers Squibb Holdings Ireland	Atazanavirholdige sammensætninger i tabletform
EP2178511B1 (en) *	2007-06-22	2011-03-02	Bristol-Myers Squibb Company	Tableted compositions containing atazanavir
CN101778625A (zh) *	2007-06-22	2010-07-14	百时美施贵宝公司	含有阿扎那韦的压片组合物
WO2009006203A1 (en) *	2007-06-29	2009-01-08	Gilead Sciences, Inc.	Therapeutic compositions and the use thereof
CN103480000A (zh) *	2007-06-29	2014-01-01	吉里德科学公司	治疗用组合物和方法
EP2288593A1 (en) *	2008-05-08	2011-03-02	Ranbaxy Laboratories Limited	Process for the preparation of 3,4-epoxy-2-amino-1-substituted butane derivatives and intermediate compounds thereof
US20120121722A1 (en)	2008-12-18	2012-05-17	Anup Avijit Choudhury	Atazanavir formulations
EP2376452A4 (en)	2009-01-12	2012-08-29	Hetero Research Foundation	NEW SULFATE POLYMORPH OF ATAZANAVIR
WO2010138338A1 (en)	2009-05-27	2010-12-02	Merck Sharp & Dohme Corp.	Hiv protease inhibitors
EP2272830A1 (en)	2009-06-18	2011-01-12	Esteve Química, S.A.	Preparation process of an antivirally heterocyclic azahexane derivative
WO2011027324A1 (en)	2009-09-03	2011-03-10	Ranbaxy Laboratories Limited	Polymorphic forms of atazanavir sulfate
JP6122639B2 (ja)	2009-10-26	2017-04-26	メルク・シャープ・エンド・ドーム・コーポレイション	インテグラーゼ阻害剤を含有する固形医薬組成物
WO2011080562A1 (en)	2009-12-29	2011-07-07	Hetero Research Foundation	Novel aza-peptides containing 2,2-disubstituted cyclobutyl and/or substituted alkoxy benzyl derivatives as antivirals
PH12012501537A1 (en)	2010-01-27	2018-02-07	Viiv Healthcare Co	Antiviral therapy
EP2542527A2 (en)	2010-03-01	2013-01-09	Lupin Limited	Process for the preparation of atazanavir sulfate substantially free of diastereomers
US20130203759A1 (en)	2010-04-09	2013-08-08	Faranak Nikfar	ATAZANAVIR SULFATE FORMULATIONS WITH IMPROVED pH EFFECT
EA201390464A1 (ru)	2010-09-28	2013-08-30	Рациофарм Гмбх	Способ сухой обработки атазанавира
WO2013014633A1 (en)	2011-07-27	2013-01-31	Ranbaxy Laboratories Limited	Process for preparation of atazanavir or its bisulfate salt
US8461347B2 (en)	2011-08-05	2013-06-11	Scinopharm Taiwan, Ltd.	Process for preparing form A of atazanavir sulfate
US9133157B2 (en)	2011-10-26	2015-09-15	Merck Canada Inc.	HIV protease inhibitors
WO2014030173A2 (en) *	2012-08-24	2014-02-27	Laurus Labs Private Limited	An improved process for the preparation of atazanavir bisulfate
WO2014036690A1 (zh) *	2012-09-04	2014-03-13	上海迪赛诺化学制药有限公司	制备阿扎那韦硫酸氢盐a型结晶的方法
EP2956439B1 (en)	2013-02-12	2019-01-09	Cipla Limited	Process for preparing atazanavir sulphate
CN104250225A (zh) *	2013-06-28	2014-12-31	上海威智医药科技有限公司	阿扎那韦磷酸盐及其制备和应用
CN104250224A (zh) *	2013-06-28	2014-12-31	上海威智医药科技有限公司	阿扎那韦富马酸盐及其制备和应用
CN104250223B (zh) *	2013-06-28	2017-04-12	上海威智医药科技有限公司	阿扎那韦氢溴酸盐及其制备和应用
CN105859611A (zh) *	2016-04-18	2016-08-17	上海现代制药海门有限公司	一种阿扎那韦硫酸氢盐a型结晶的制备方法
CN109251165B (zh) *	2018-10-02	2022-09-23	国药集团川抗制药有限公司	阿扎那韦达二4-氨基苯磺酸盐及其制备方法
CN111349042B (zh) *	2018-12-20	2023-07-14	陕西理工大学	一种阿扎那韦单晶及其制备方法
US12083099B2 (en)	2020-10-28	2024-09-10	Accencio LLC	Methods of treating symptoms of coronavirus infection with viral protease inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL106600A (en) *	1992-08-07	1997-09-30	Sankyo Co	Peptides, pharmaceutical compositions containing the same and processes for the preparation thereof
TW409125B (en) *	1996-04-22	2000-10-21	Novartis Ag	Antivirally active heterocyclic azahexane derivatives
US5849911A (en) *	1996-04-22	1998-12-15	Novartis Finance Corporation	Antivirally active heterocyclic azahexane derivatives

1998
- 1998-12-21 US US09/217,538 patent/US6087383A/en not_active Expired - Lifetime
- 1998-12-22 SK SK1062-2000A patent/SK283975B6/sk not_active IP Right Cessation
- 1998-12-22 GE GEAP19985466A patent/GEP20033026B/en unknown
- 1998-12-22 AT AT98964878T patent/ATE219057T1/de active
- 1998-12-22 CZ CZ20002564A patent/CZ293507B6/cs not_active IP Right Cessation
- 1998-12-22 RU RU2000119792/04A patent/RU2186070C2/ru active
- 1998-12-22 HU HU0101389A patent/HU227196B1/hu unknown
- 1998-12-22 IL IL13738498A patent/IL137384A0/xx active IP Right Grant
- 1998-12-22 TR TR2000/01876T patent/TR200001876T2/xx unknown
- 1998-12-22 NZ NZ504417A patent/NZ504417A/en not_active IP Right Cessation
- 1998-12-22 BR BR9814736-6A patent/BR9814736A/pt not_active Application Discontinuation
- 1998-12-22 WO PCT/US1998/027382 patent/WO1999036404A1/en not_active Ceased
- 1998-12-22 DE DE69806067T patent/DE69806067T2/de not_active Expired - Lifetime
- 1998-12-22 JP JP2000540121A patent/JP4860037B2/ja not_active Expired - Lifetime
- 1998-12-22 CA CA002317736A patent/CA2317736C/en not_active Expired - Lifetime
- 1998-12-22 UA UA2000084931A patent/UA59432C2/uk unknown
- 1998-12-22 PL PL342019A patent/PL190744B1/pl unknown
- 1998-12-22 PT PT98964878T patent/PT1056722E/pt unknown
- 1998-12-22 KR KR1020007007885A patent/KR100559283B1/ko not_active Expired - Fee Related
- 1998-12-22 EP EP98964878A patent/EP1056722B1/en not_active Expired - Lifetime
- 1998-12-22 ES ES98964878T patent/ES2178300T3/es not_active Expired - Lifetime
- 1998-12-22 RO ROA200000717A patent/RO118869B1/ro unknown
- 1998-12-22 AU AU20101/99A patent/AU735875B2/en not_active Expired
- 1998-12-22 DK DK98964878T patent/DK1056722T3/da active
- 1998-12-22 EE EEP200000798A patent/EE04434B1/et unknown
- 1998-12-22 CN CN98812741A patent/CN1116282C/zh not_active Expired - Lifetime
1999
- 1999-01-05 MY MYPI99000020A patent/MY114838A/en unknown
- 1999-01-05 ZA ZA9900056A patent/ZA9956B/xx unknown
- 1999-01-12 UY UY25345A patent/UY25345A1/es not_active Application Discontinuation
- 1999-01-15 TW TW088100623A patent/TW531531B/zh not_active IP Right Cessation
- 1999-01-17 EG EG5699A patent/EG23936A/xx active
- 1999-01-18 AR ARP990100179A patent/AR014417A1/es active IP Right Grant
- 1999-01-19 CO CO99002578A patent/CO4970820A1/es unknown
- 1999-01-20 PE PE1999000047A patent/PE20000185A1/es not_active IP Right Cessation
2000
- 2000-06-06 LV LVP-00-78A patent/LV12522B/en unknown
- 2000-07-14 LT LT2000067A patent/LT4780B/lt not_active IP Right Cessation
- 2000-07-17 BG BG104618A patent/BG64774B1/bg unknown
- 2000-07-19 NO NO20003692A patent/NO315605B1/no not_active IP Right Cessation
- 2000-07-19 IL IL137384A patent/IL137384A/en not_active IP Right Cessation
2008
- 2008-12-17 JP JP2008321240A patent/JP2009102357A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
LV12522B (en)	2000-10-20
CO4970820A1 (es)	2000-11-07
CA2317736C (en)	2004-11-02
RO118869B1 (ro)	2003-12-30
NO20003692D0 (no)	2000-07-19
PL342019A1 (en)	2001-05-07
JP2002509136A (ja)	2002-03-26
UA59432C2 (uk)	2003-09-15
LV12522A (en)	2000-08-20
PT1056722E (pt)	2002-09-30
CZ293507B6 (cs)	2004-05-12
HK1033458A1 (en)	2001-08-31
BR9814736A (pt)	2000-10-24
GEP20033026B (en)	2003-07-25
HK1033667A1 (en)	2001-09-14
RU2186070C2 (ru)	2002-07-27
SK283975B6 (sk)	2004-06-08
AR014417A1 (es)	2001-02-28
EG23936A (en)	2008-01-14
LT4780B (lt)	2001-04-25
EE200000798A (et)	2002-06-17
CN1283188A (zh)	2001-02-07
WO1999036404A1 (en)	1999-07-22
DE69806067T2 (de)	2003-01-23
CN1116282C (zh)	2003-07-30
EP1056722A4 (en)	2001-01-10
HUP0101389A2 (hu)	2001-08-28
AU735875B2 (en)	2001-07-19
IL137384A0 (en)	2001-07-24
US6087383A (en)	2000-07-11
DE69806067D1 (de)	2002-07-18
NZ504417A (en)	2001-09-28
DK1056722T3 (da)	2002-09-30
AU2010199A (en)	1999-08-02
JP4860037B2 (ja)	2012-01-25
JP2009102357A (ja)	2009-05-14
ATE219057T1 (de)	2002-06-15
LT2000067A (en)	2000-11-27
IL137384A (en)	2006-08-01
SK10622000A3 (sk)	2001-02-12
MY114838A (en)	2003-01-31
BG104618A (en)	2001-02-28
HU227196B1 (en)	2010-10-28
EP1056722B1 (en)	2002-06-12
CA2317736A1 (en)	1999-07-22
KR100559283B1 (ko)	2006-03-15
HUP0101389A3 (en)	2003-07-28
UY25345A1 (es)	2000-12-29
TW531531B (en)	2003-05-11
NO20003692L (no)	2000-07-19
EE04434B1 (et)	2005-02-15
ES2178300T3 (es)	2002-12-16
PE20000185A1 (es)	2000-05-14
NO315605B1 (no)	2003-09-29
BG64774B1 (bg)	2006-03-31
EP1056722A1 (en)	2000-12-06
KR20010034221A (ko)	2001-04-25
CZ20002564A3 (cs)	2000-10-11
PL190744B1 (pl)	2006-01-31
ZA9956B (en)	2000-07-05

Publication	Publication Date	Title
TR200001876T2 (tr)	2000-11-21	HIV proteaz inhibitörünün bisülfat tuzu.
CY1109886T1 (el)	2014-09-10	Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
DK0931788T3 (da)	2002-11-25	Metalloproteasehæmmere
DE69919397D1 (de)	2004-09-16	Thrombin-inhibitoren
DK1385515T3 (da)	2008-10-27	Spiropyrazole forbindelser
YU5503A (sh)	2006-05-25	Nesteroidni supresori zapaljenja
CY1106247T1 (el)	2011-06-08	Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
ATE292634T1 (de)	2005-04-15	Inhibitoren der alpha-l beta-2 vermittelten zelladhäsion
CY1106132T1 (el)	2011-06-08	Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου
NO20043016L (no)	2004-07-15	6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
DE69812634D1 (de)	2003-04-30	Metalloproteinase-inhibitoren
TR200403436T2 (tr)	2005-03-21	Kristalin 1-metilkarbapenem türevleri.
SE0103710D0 (sv)	2001-11-07	Compounds
HRP20080057T3 (en)	2008-02-29	9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
AP2002002466A0 (en)	2002-06-30	3-heterocycliylpropanohydroxamic acid PCP INHIBITORS.
BG107003A (en)	2003-04-30	Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
TR200001909T2 (tr)	2000-12-21	Matris metaloprotez inhibitörleri.
DE60033809D1 (de)	2007-04-19	Inhibitoren von metalloproteinasen
IT1320107B1 (it)	2003-11-18	Procedimento per la preparazione di derivati tassanici.
TR200100906T2 (tr)	2001-07-23	Trombin inhibitörleri olarak benzamid türevleri
BR0009795A (pt)	2002-01-08	Processo para a ppeparação de um composto da fórmula (i), e, composto
ECSP982595A (es)	1999-02-11	Compuestos farmaceuticos
UY26778A1 (es)	2002-01-31	Derivados de ácido heteroarilalcanoico.
CY1110529T1 (el)	2015-04-29	Παρασκευη ν-υποκατεστημενων 2,7-διαλκυλο-4-υδροξυ-5-αμινο-8-αρυλοοκτανοϋλαμιδιων
SE9901338D0 (sv)	1999-04-15	Novel process